TTC13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.001600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.577800E-01
Normal-vs-Stage2
4.901600E-01
Normal-vs-Stage3
3.339200E-01
Normal-vs-Stage4
4.797400E-01
Stage1-vs-Stage2
1.442390E-01
Stage1-vs-Stage3
5.810100E-02
Stage1-vs-Stage4
3.149600E-01
Stage2-vs-Stage3
1.449010E-01
Stage2-vs-Stage4
8.889600E-01
Stage3-vs-Stage4
1.921760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.997400E-01
Normal-vs-AfricanAmerican
5.111200E-01
Normal-vs-Asian
5.563600E-01
Caucasian-vs-AfricanAmerican
9.814400E-01
Caucasian-vs-Asian
6.033400E-01
AfricanAmerican-vs-Asian
6.988400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.315600E-01
Normal-vs-Female
4.686800E-01
Male-vs-Female
1.620220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.779200E-01
Normal-vs-Age(41-60Yrs)
4.891200E-01
Normal-vs-Age(61-80Yrs)
4.944800E-01
Normal-vs-Age(81-100Yrs)
5.851200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.030400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.111800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.764000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.933200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.439600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.611400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.292800E-01
Normal-vs-Daily Drinker
4.032200E-01
Normal-vs-Weekly Drinker
3.967000E-01
Normal-vs-Occasional Drinker
4.889400E-01
Normal-vs-Social Drinker
5.141200E-01
Non Drinker-vs-Daily Drinker
8.157600E-02
Non Drinker-vs-Weekly Drinker
5.968600E-01
Non Drinker-vs-Occasional Drinker
6.209800E-01
Non Drinker-vs-Social Drinker
8.574000E-01
Daily Drinker-vs-Weekly Drinker
1.529180E-01
Daily Drinker-vs-Occasional Drinker
1.628170E-01
Daily Drinker-vs-Social Drinker
1.806000E-01
Weekly Drinker-vs-Occasional Drinker
4.517200E-01
Weekly Drinker-vs-Social Drinker
5.848200E-01
Occasional Drinker-vs-Social Drinker
7.979800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.708010E-01
Normal-vs-Grade 2
7.839900E-03
Normal-vs-Grade 3
1.202180E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.001400E-01
Grade 1-vs-Grade 3
4.370800E-01
Grade 1-vs-Grade 4
1.708010E-01
Grade 2-vs-Grade 3
8.136800E-01
Grade 2-vs-Grade 4
7.839900E-03
Grade 3-vs-Grade 4
1.202180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.536200E-01
Normal-vs-NonDiabetic
5.096000E-01
Diabetic-vs-NonDiabetic
3.079000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.835400E-01
Normal-vs-NoPancreatitis
4.914000E-01
Pancreatitis-vs-NoPancreatitis
9.096800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.950800E-01
Normal-vs-N1
4.686600E-01
N0-vs-N1
5.048200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.493800E-01
Normal-vs-TP53-NonMutant
6.641200E-01
TP53-Mutant-vs-TP53-NonMutant
1.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
